VCEL Earnings

VCEL reported its earnings on 2026-05-07, showcasing a revenue of 68.42M against an estimate of 63.80M, resulting in a 7.25% surprise. The EPS was -0.12, surpassing the expected -0.14 by 20%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following VCEL's earnings announcement on 2026-05-07, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, VCEL's stock price tends to shift by an average of 0.35% in the 10 days leading up to earnings and -2.44% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate VCEL's annual revenue to reach 74.34M, while the EPS is projected at 0.09. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between VCEL's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, VCEL's stock price typically moves by 0.35% in the 10 days before its earnings and -2.44% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.09 and revenue of 74.34M.

The earnings call reflects strong financial performance with record-high gross and EBITDA margins, significant revenue growth, and a robust cash position. The Q&A highlights positive sentiment towards pricing strategies and surgeon adoption, though some guidance lacks specifics. Despite slightly lower MACI growth guidance for 2026, the overall outlook remains optimistic with ongoing expansion efforts and potential BARDA RFP opportunities. The positive financial metrics and strategic growth initiatives suggest a likely stock price increase in the short term.